Therefore, the cause of decreased sperm quality in patients with COVID‐19 may be dysfunction of the hypothalamic‐pituitary‐testicular axis, which leads to abnormal secretion of gonadotropin‐releasing hormone, LH, and FSH, affecting testosterone production and spermatogenesis. This evidence concerns the gene BRD2 and COVID-19.